Firmable Raises $14M for AI Sales Platform
Melbourne-based Firmable has raised $14 million to expand its AI-native sales platform globally. The funding round was led by Airtree, signaling strong venture capital interest in vertical SaaS solutions that use AI to automate and streamline sales and CRM workflows.
The latest funding round brings Firmable's total capital raised to $15.7 million. This Series A investment follows a $9 million seed round in 2024, also led by Airtree, which has a history of backing successful Asia-Pacific tech companies that expand globally, including Canva and Airwallex. Firmable was co-founded by Leigh Jasper, Paul Perrett, and Karthik Venkatasubramanian, veterans of the enterprise software company Aconex. The founding team has a track record of scaling globally from Australia, having sold Aconex to Oracle for $1.6 billion. The company's core strategy is to own its underlying dataset, a key differentiator in a market where many AI startups build on licensed third-party data. Firmable uses AI-driven web aggregation and language models to continuously refresh its proprietary data on companies and contacts, aiming to provide more accurate and timely sales intelligence than competitors. This focus on proprietary data is designed to solve a common problem for sales teams, particularly outside the U.S., where data from major providers is often stale, duplicated, or inaccurate. Co-CEO Paul Perrett notes that most US-built sales tools underperform internationally, a gap Firmable aims to fill with its AI-native platform. The new capital is earmarked for a significant push into the United States market. Funds will also be used to further develop the platform's AI agents, which are designed to execute and automate sales tasks, not just provide suggestions. Firmable already serves over 1,000 customers, including notable names like Monday.com, Canon, CBRE, and G2, across Australia, New Zealand, and eight other Asia-Pacific markets. The company provides data on over 3 million companies and 25 million contacts in the Australia and New Zealand region alone.
